Welcome to CSNpharm! For Research Use Only!
PAR
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN13782 | Vorapaxar | 618385-01-6 | Vorapaxar is a thrombin receptor protease-activated receptor PAR-1 antagonist |
| CSN17809 | TRAP-6 | 141136-83-6 | TRAP-6 is protease-activated receptor 1 (PAR1) agonist. |
| CSN23082 | RWJ-56110 | 252889-88-6 | RWJ-56110 is a selective protease-activated receptor-1 (PAR1) antagonist. It blocks thrombin-induced platelet aggregation and activation of MAPK in HUVECs. |
| CSN23119 | Protease-Activated Receptor-2, amide | 190383-13-2 | Protease-Activated Receptor-2, amide (SLIGKV-NH2) is a highly potent protease-activated receptor-2 (PAR2) activating peptide. |
| CSN23110 | SCH79797 dihydrochloride | 1216720-69-2 | Potent, selective non-peptide PAR1 antagonist |
| CSN13679 | Parmodulin 2 | 423735-93-7 | ML-161 is an allosteric and reversible inhibitor of proteinase-activated receptor 1 PAR1 with IC50 of 026 M |
| CSN24477 | I-191 | 1690172-25-8 | I-191 inhibited PAR2 binding of and activation by structurally distinct PAR2 agonists (trypsin, peptide, nonpeptide) at nanomolar concentrations. |
| CSN25350 | GB-88 | 1416435-96-5 | GB-88 is an oral, selective non-peptide antagonist of PAR2. It inhibits PAR2 activated Ca2+ release with an IC50 of 2 µM. |
| CSN22822 | FR-171113 | 173904-50-2 | FR 171113 is a protease-activated receptor 1 (PAR1) antagonist. |
| CSN24830 | ENMD-1068 | 789488-77-3 | ENMD-1068 is a PAR2 anatagonist with IC50 value of 1.2mM. |
| CSN22353 | AZ3451 | 2100284-59-9 | AZ3451 is a protease-activated receptor-2 (PAR2) antagonist. |
| CSN21664 | PAR-4 Agonist Peptide, amide | 352017-71-1 | AY-NH2 is a peptide agonist of proteinase-activated receptor 4 (PAR4) that induces aggregation of platelets in vitro. |
| CSN24081 | Atopaxar | 751475-53-3 | Atopaxar, also known as E5555, is a potent and orally-active PAR-1 inhibitor. E5555 inhibited the binding of a high-affinity thrombin receptor-activating peptide ([(3)H]haTRAP) to PAR-1 with a half maximal inhibitory concentration (IC(50)) value of 0.019μM. E5555 showed potent inhibitory effects on human platelet aggregation induced by thrombin and TRAP with IC(50) values of 0.064 and 0.031μM, respectively. E5555 showed potent and selective inhibitory effects on guinea pig platelet aggregation induced by thrombin and TRAP with IC(50) values of 0.13 and 0.097μM, respectively. E5555 could be a therapeutic option for atherothrombotic disease. |
| CSN18572 | AC-55541 | 916170-19-9 | AC-55541 is a small-molecule protease-activated receptor 2 PAR2 agonist and activates PAR2 signaling in cellular proliferation assays phosphatidylinositol hydrolysis assays and Ca2 mobilization assays with potencies ranging from 200 to 1000 nM |
| CSN22664 | AC-264613 | 1051487-82-1 | AC 264613 is a potent and selective protease-activated receptor 2 (PAR2) agonist with pEC50 = 7.5. |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
